***APOGÉE-Net/CanGèneTest ­ EuroGentest Ancillary Meeting at the International Congress of Human Genetics in Montreal October 13 2011***
At the 12th International Congress of Human Genetics held in Montreal in October 2011, EuroGentest and APOGEE-Net/CanGeneTest jointly organized a session entitled "Challenges in the Translation of Genomic Innovations into Clinical Care". The session was opened by François Rousseau (Université Laval) who presented the APOGEE-Net/CanGeneTest Network and its role in addressing the challenges of translating genomic and genetic innovations into the health care system. Gert Matthijs (University of Leuven) presented the EuroGentest Network and its role in the improvement and standardization of quality in genetic testing. Joris Vermeesch (University of Leuven) described two pilot studies of external quality assessment of constitutional molecular karyotyping, and  Helena Kääriäinen (University of Helsinki) described the impact of the increasing importance of genetic testing in health care. Daniel Reinharz (Université Laval) presented cost/effectiveness and cost/utility simulations for selected genetic and genomic health innovations, and Renaldo Battista (Université de Montréal) discussed the role of health technology assessment in the translational process.
 
The session was a success as it attracted over 60 participants despite the concurrent presentation of several other events, underlining the importance of these questions to the medical and scientific community. One of the conclusions of this event was that there is strong complementarity between the activities of each Network and that there is room for even more synergy between the different teams working in this area. More information on the session can be obtained by following this link :
http://www.eurogentest.org/web/info/public/ICHG_AncillaryEvent2011.xhtml=

APOGEE-Net/CanGèneTest is an international research and knowledge network studying health care and health policy challenges in genetic services, including genetic laboratory services. Its general objective is to streamline the technology transfer of clinically useful and cost/effective genetic innovations towards the health care system and support the development of evidence-informed health policies.Through a multidisciplinary approach, we aim to study the path that links the fundamental research discoveries in genetics to the use of molecular diagnostic tests in the clinical setting. Moreover, with our e-Newsletter and this WEB site, we expect to contribute to disseminate timely and relevant scientific materials to colleagues interested in this broad field of research, downstream of the gene discovery, necessary to translate the clinically valid and useful discoveries into novel health care services.

Subscribe to the Newsletter here.